Travere Therapeutics TVTX
NASDAQ TVTX
$51.99 +0.36 (+0.70%)
At close: Nov 10, 2026 · 4:00 PM EST

Travere Therapeutics (TVTX) Net Short-Term Debt Issued (Repaid) (2014)

Updated

Analysis

Travere Therapeutics (TVTX) Net Short-Term Debt Issued (Repaid) (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -4.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -24.00 Mn
10 Travere Therapeutics 4.85 Bn 4.44 Bn 221.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 3.61 Mn
API Access

Travere Therapeutics Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TVTX&period=max&api_key=YOUR_API_KEY